Pioneer Fund's Therapeutics Portfolio

Ply Health helps behavioral health providers see more patients by getting them in a network with insurance companies.

Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.

Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients

Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications.

OM Therapeutics provides a fresh approach to cannabis and well-being with products that offers a balanced and mindful lifestyle.

Ditto Bio develops AI-driven therapeutics by harnessing parasite biology to treat autoimmune diseases effectively.

Argon AI: Automating life sciences activities in clinical and commercial settings.

Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.

Uncommon Therapeutics focuses on building drugs for rare diseases using cutting-edge technology.

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.